Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma
Open Access
- 21 April 2023
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 15 (8) , 3107-3119
Abstract
Urinary bladder urothelial carcinoma (UBUC) encompasses about 90% of all bladder cancer cases, and the mainstream treatment is the transurethral resection of the bladder tumor followed by intravesical instillation. High rates of mortality, recurrence, and progression in bladder cancer have stimulated the search for alternative adjuvant therapies. The aim of this study was to investigate the potential of melatonin as adjuvant therapy in bladder cancer. Cell viability and clonogenic ability were assessed by an MTT assay and colony formation. Cell cycle and apoptosis analysis were performed by flow cytometry and Hoechst 33342 staining, while cell metastasis capacity was measured by wound healing and transwell assays. Potential mechanisms were investigated by an oncology array and verified via western blotting. The melatonin treatment significantly reduced T24 and UMUC3 bladder cancer cell proliferation and clonogenic ability. G1 arrest and sub-G1 accumulation in the T24 and UMUC3 cells led to cell proliferation suppression and cell death, and Hoechst 33342 staining further verified the apoptosis induction directly by melatonin. Moreover, melatonin weakened cell motility and invasiveness. Based on the oncology array results, we demonstrated that melatonin exerts its anti-cancer effect by down-regulating the HIF-1α and NF-κB pathways and downstream pathways, including Bcl-2, leading to cell cycle arrest and apoptosis induction in the UBUC cells. Overall, these findings support the potential of melatonin as adjuvant therapy in bladder cancer.Keywords
This publication has 50 references indexed in Scilit:
- Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathwayNutrition & Metabolism, 2013
- Hypoxia-Induced Modulation of Apoptosis and BCL-2 Family Proteins in Different Cancer Cell TypesPLOS ONE, 2012
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κBPLOS ONE, 2010
- High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinomaExperimental and Therapeutic Medicine, 2010
- Ponicidin Inhibits Monocytic Leukemia Cell Growth by Induction of ApoptosisInternational Journal of Molecular Sciences, 2008
- Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated ratsLife Sciences, 2008
- Regulation of hypoxia-inducible factor-1α by NF-κBBiochemical Journal, 2008
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Hypoxia Up-Regulates Hypoxia-Inducible Factor-1α Transcription by Involving Phosphatidylinositol 3-Kinase and Nuclear Factor κB in Pulmonary Artery Smooth Muscle CellsMolecular Biology of the Cell, 2007